Admission Date:  [**2148-3-25**]       Discharge Date:  [**2148-4-3**]  Date of Birth:   [**2097-9-27**]       Sex:  M  Service:  TRANSPLANT SURGERY  HISTORY OF PRESENT ILLNESS:  Mr. [**Known lastname 71430**] is a 50-year-old male, with a past medical history significant for hepatitis C, portal hypertension, gastric varices, and hepatic encephalopathy, who underwent a living-related liver transplant on [**2148-3-5**].
His postoperative course was notable for hepatorenal syndrome requiring hemodialysis with extubation on postoperative day #5, and echocardiogram which demonstrated a decreased ejection fraction at 35%, with 2+ mitral regurgitation on approximately postoperative day #5.
Status post living-related liver transplantation [**2148-3-5**].
Lopressor 25 mg po bid.
Lasix 40 mg po bid.
Cyclosporin 225 mg po bid.
Hydralazine 20 mg po q 6 h. 6.
Valcyte 450 mg po qod.
Colace 100 mg po bid.
Prevacid 30 mg po qd.
Prednisone 20 mg po qd.
The patient was immediately placed on a lasix drip for aggressive diuresis.
Given his elevated creatinine level, his cyclosporin was held.
On hospital day #3, the patient was weaned from his lasix drip and was started on intravenous lasix [**Hospital1 **].
His skin staples were removed at this time, as well.
A central venous line was placed for poor access into the left subclavian vein on hospital day #3.
His Foley catheter was removed at this time, and his transplant medications were resumed.
The patient continued to be diuresed, was advanced to a regular diet, and was receiving physical therapy treatment until the time of discharge on hospital day #10.
He will be discharged to the [**Hospital6 310**] for physical therapy and intravenous lasix diuresis.
Status post central venous line placement.
Cyclosporin 75 mg po q 12 h. 2.
Fluconazole 400 mg po qd.
Furosemide 60 mg IV bid.
Hydralazine 20 mg po q 6 h. 5.
Insulin as directed per sliding scale.
Imdur 30 mg po qd.
Pantoprazole 25 mg po bid.
CellCept 1,000 mg po bid.
Protonix 40 mg po qd.
11.Bactrim SS 1 tablet po qd.
He was also instructed to have his labs drawn twice weekly for CBC, chem-10, LFTs, and cyclosporin levels.
He will be discharged with a left subclavian central venous line for intravenous access.
Once he is able to have a peripheral IV established, this line may be removed.
